Ofosu Adjei-Afriyie completed his Master’s in Cellular and Molecular Medicine with the Lochmüller lab in December 2025.
Ofosu’s research focused on insulin resistance in Myotonic Dystrophy Type 1 (DM1). He investigated the mechanisms that underlie the pathophysiology of insulin resistance in DM1 by exploring how exercise impacted animal and cellular models of the disease.
For his undergraduate honours project, Ofosu joined the Lochmüller lab to study the therapeutic effects of MuSK agonist antibodies on mutant AGRIN CMS mice models.
Prior to entering the lab as an honours student, Ofosu conducted research under the supervison of Dr. Adam Rudner. With Dr. Rudner, he has discovered his own M. foliorum bacteriophage and has gone on to annotate and characterize an additional bacteriophage. In the winter of 2021, Ofosu extended his research with Dr. Rudner to investigate an uncharacterized tail assembly chaperone frameshift in bacteriophage Winzigispinne.
